FDA Ethics Under Spotlight Of House Oversight Subcommittee Investigation
This article was originally published in The Gray Sheet
Executive Summary
The House Energy & Commerce/Oversight & Investigations Subcommittee is shifting its ongoing ethics investigation toward FDA, Rep. Joe Barton (R-Texas) said May 18 at an NIH ethics hearing
You may also be interested in...
NIH Scientists Propose Lifting Stock Restrictions For Most Staff
The NIH Assembly of Scientists is proposing that the agency revise its recently issued ethics regulations to impose different requirements on employees with varying levels of authority
NIH Scientists Propose Lifting Stock Restrictions For Most Staff
The NIH Assembly of Scientists is proposing that the agency revise its recently issued ethics regulations to impose different requirements on employees with varying levels of authority
FDA Conflict Of Interest Policies Will Be Reviewed By House Committee
The House Energy & Commerce Committee will review FDA's conflict-of-interest procedures as part of an expanding probe that originally focused on National Institutes of Health employee consulting arrangements